Abstract
AbstractLevels of carbamazepine, carbamazepine‐10,11‐epoxide and −10,11‐diol were measured in the plasma of 40 patients with affective disorders chronically treated with carbamazepine. Steady‐state plasma levels of carbamazepine were not related to the degree of prophylactic response. In contrast, the mean plasma concentrations of the −10,11‐epoxide metabolite of carbamazepine were significantly lower in patients with complete response than in patients with partial response or in nonresponders. The ratios of carbamazepine‐10,11‐diol concentrations to the parent drug dose were found to be significantly different in the three response groups. These results suggest that the pharmacokinetic parameters of the metabolites might be used for the prediction of individual prophylactic efficacy at the initial stage of carbamazepine therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Human Psychopharmacology: Clinical and Experimental
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
